Rare diseases
Investigational molecules
Locations
A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandEvaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
PolandLong-term safety study of ribociclib with letrozole, tamoxifen, or goserelin acetate in patients with HR-positive, HER2-negative advanced or metastatic breast cancer
PolandStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
PolandStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
PolandStudy of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals
PolandStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
PolandStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
PolandLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
PolandStudy of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection
PolandStudy of zorevunersen to reduce seizures in patients with Dravet syndrome
PolandLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
